Advances in Immunotherapy for Adult Glioblastoma

SIMPLE SUMMARY: Therapy failure and disease recurrence are hallmarks of glioblastoma (GBM), the most common and lethal tumor in adults that originates in the brain. Despite aggressive standards of care, tumor recurrence is inevitable with no standardized second-line therapy. Recent clinical studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Chokshi, Chirayu R., Brakel, Benjamin A., Tatari, Nazanin, Savage, Neil, Salim, Sabra K., Venugopal, Chitra, Singh, Sheila K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305609/
https://www.ncbi.nlm.nih.gov/pubmed/34298615
http://dx.doi.org/10.3390/cancers13143400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305609/
https://www.ncbi.nlm.nih.gov/pubmed/34298615
http://dx.doi.org/10.3390/cancers13143400

Ejemplares similares